Natural Vascular Scaffolding Treatment Promotes Outward Remodeling During Arteriovenous Fistula Development in Rats
Following creation, an arteriovenous fistula (AVF) must mature (i.e., enlarge lumen to allow high blood flow) before being used for hemodialysis. AVF maturation failure rates are high, and currently, there are no effective therapy to treat this problem. The maturation process is likely affected by t...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2021.622617/full |
id |
doaj-c0aa0b435f0e49af8c5eb689d08d2d2e |
---|---|
record_format |
Article |
spelling |
doaj-c0aa0b435f0e49af8c5eb689d08d2d2e2021-02-15T06:03:46ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852021-02-01910.3389/fbioe.2021.622617622617Natural Vascular Scaffolding Treatment Promotes Outward Remodeling During Arteriovenous Fistula Development in RatsYan-Ting Shiu0Yan-Ting Shiu1Yuxia He2Jason C. S. Tey3Marina Knysheva4Blake Anderson5Katalin Kauser6Division of Nephrology and Hypertension, University of Utah School of Medicine, Salt Lake City, UT, United StatesVeterans Affairs Medical Center, Salt Lake City, UT, United StatesDivision of Nephrology and Hypertension, University of Utah School of Medicine, Salt Lake City, UT, United StatesDivision of Nephrology and Hypertension, University of Utah School of Medicine, Salt Lake City, UT, United StatesDivision of Nephrology and Hypertension, University of Utah School of Medicine, Salt Lake City, UT, United StatesAlucent Biomedical Inc., Salt Lake City, UT, United StatesAlucent Biomedical Inc., Salt Lake City, UT, United StatesFollowing creation, an arteriovenous fistula (AVF) must mature (i.e., enlarge lumen to allow high blood flow) before being used for hemodialysis. AVF maturation failure rates are high, and currently, there are no effective therapy to treat this problem. The maturation process is likely affected by the integrity of the vascular extracellular matrix (ECM). Natural Vascular Scaffolding (NVS) Therapy is a new technology that interlinks collagen and elastin via photoactivation of a locally delivered small molecule (4-amino-1,8-naphtalamide). We hypothesized that NVS Therapy may improve AVF remodeling by preserving ECM integrity. AVFs were created in Wistar male rats by connecting the femoral vein (end) to femoral artery (side) in the same limb. Immediately after blood flow was restored to dilate the femoral vein by arterial pressure, a 10 μl-drop of the NVS compound (2 mg/ml) was placed on the anastomosis perivascularly. Following 5-min incubation, the NVS treated area was exposed to 1-min illumination by 450-nm light. The control group received 10 μl-drop of phosphate buffered saline (PBS) and the same light activation. The skin was closed, and rats were euthanized 4 weeks (n = 6–9 per group) post-AVF creation for histology, morphometry, immunohistochemistry (IHC), and multiphoton microscopy for second-harmonic-generation evaluation of collagen fibers. The vascular thickness was similar in both groups. The AVF vein’s open lumen area and % open lumen area in NVS-treated rats were significantly larger than in PBS-treated rats (4.2-fold p = 0.014 and 2-fold p = 0.009, respectively). The inflammatory markers IL-6 and MMP-9 in the AVF walls were significantly decreased in the NVS group than the PBS group. Collagen fibers in the vascular wall trended toward perpendicular alignment to the lumen circumference in the NVS-treated AVFs, with more defined shape but less area than in the PBS-treated AVFs. These results indicate that the NVS Therapy exerted changes in collagen, which may influence AVF maturation. Rats tolerated the NVS treatment well, and the lack of cell death by the treatment was confirmed in cell culture experiments. These results suggest that NVS treatment is safe and may have therapeutic potential by facilitating lumen expansion to enhanced AVF maturation in patients.https://www.frontiersin.org/articles/10.3389/fbioe.2021.622617/fullarteriovenous fistulaextracellular matrixneointimal formationlumen expansiondialysislocal drug delivery |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yan-Ting Shiu Yan-Ting Shiu Yuxia He Jason C. S. Tey Marina Knysheva Blake Anderson Katalin Kauser |
spellingShingle |
Yan-Ting Shiu Yan-Ting Shiu Yuxia He Jason C. S. Tey Marina Knysheva Blake Anderson Katalin Kauser Natural Vascular Scaffolding Treatment Promotes Outward Remodeling During Arteriovenous Fistula Development in Rats Frontiers in Bioengineering and Biotechnology arteriovenous fistula extracellular matrix neointimal formation lumen expansion dialysis local drug delivery |
author_facet |
Yan-Ting Shiu Yan-Ting Shiu Yuxia He Jason C. S. Tey Marina Knysheva Blake Anderson Katalin Kauser |
author_sort |
Yan-Ting Shiu |
title |
Natural Vascular Scaffolding Treatment Promotes Outward Remodeling During Arteriovenous Fistula Development in Rats |
title_short |
Natural Vascular Scaffolding Treatment Promotes Outward Remodeling During Arteriovenous Fistula Development in Rats |
title_full |
Natural Vascular Scaffolding Treatment Promotes Outward Remodeling During Arteriovenous Fistula Development in Rats |
title_fullStr |
Natural Vascular Scaffolding Treatment Promotes Outward Remodeling During Arteriovenous Fistula Development in Rats |
title_full_unstemmed |
Natural Vascular Scaffolding Treatment Promotes Outward Remodeling During Arteriovenous Fistula Development in Rats |
title_sort |
natural vascular scaffolding treatment promotes outward remodeling during arteriovenous fistula development in rats |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Bioengineering and Biotechnology |
issn |
2296-4185 |
publishDate |
2021-02-01 |
description |
Following creation, an arteriovenous fistula (AVF) must mature (i.e., enlarge lumen to allow high blood flow) before being used for hemodialysis. AVF maturation failure rates are high, and currently, there are no effective therapy to treat this problem. The maturation process is likely affected by the integrity of the vascular extracellular matrix (ECM). Natural Vascular Scaffolding (NVS) Therapy is a new technology that interlinks collagen and elastin via photoactivation of a locally delivered small molecule (4-amino-1,8-naphtalamide). We hypothesized that NVS Therapy may improve AVF remodeling by preserving ECM integrity. AVFs were created in Wistar male rats by connecting the femoral vein (end) to femoral artery (side) in the same limb. Immediately after blood flow was restored to dilate the femoral vein by arterial pressure, a 10 μl-drop of the NVS compound (2 mg/ml) was placed on the anastomosis perivascularly. Following 5-min incubation, the NVS treated area was exposed to 1-min illumination by 450-nm light. The control group received 10 μl-drop of phosphate buffered saline (PBS) and the same light activation. The skin was closed, and rats were euthanized 4 weeks (n = 6–9 per group) post-AVF creation for histology, morphometry, immunohistochemistry (IHC), and multiphoton microscopy for second-harmonic-generation evaluation of collagen fibers. The vascular thickness was similar in both groups. The AVF vein’s open lumen area and % open lumen area in NVS-treated rats were significantly larger than in PBS-treated rats (4.2-fold p = 0.014 and 2-fold p = 0.009, respectively). The inflammatory markers IL-6 and MMP-9 in the AVF walls were significantly decreased in the NVS group than the PBS group. Collagen fibers in the vascular wall trended toward perpendicular alignment to the lumen circumference in the NVS-treated AVFs, with more defined shape but less area than in the PBS-treated AVFs. These results indicate that the NVS Therapy exerted changes in collagen, which may influence AVF maturation. Rats tolerated the NVS treatment well, and the lack of cell death by the treatment was confirmed in cell culture experiments. These results suggest that NVS treatment is safe and may have therapeutic potential by facilitating lumen expansion to enhanced AVF maturation in patients. |
topic |
arteriovenous fistula extracellular matrix neointimal formation lumen expansion dialysis local drug delivery |
url |
https://www.frontiersin.org/articles/10.3389/fbioe.2021.622617/full |
work_keys_str_mv |
AT yantingshiu naturalvascularscaffoldingtreatmentpromotesoutwardremodelingduringarteriovenousfistuladevelopmentinrats AT yantingshiu naturalvascularscaffoldingtreatmentpromotesoutwardremodelingduringarteriovenousfistuladevelopmentinrats AT yuxiahe naturalvascularscaffoldingtreatmentpromotesoutwardremodelingduringarteriovenousfistuladevelopmentinrats AT jasoncstey naturalvascularscaffoldingtreatmentpromotesoutwardremodelingduringarteriovenousfistuladevelopmentinrats AT marinaknysheva naturalvascularscaffoldingtreatmentpromotesoutwardremodelingduringarteriovenousfistuladevelopmentinrats AT blakeanderson naturalvascularscaffoldingtreatmentpromotesoutwardremodelingduringarteriovenousfistuladevelopmentinrats AT katalinkauser naturalvascularscaffoldingtreatmentpromotesoutwardremodelingduringarteriovenousfistuladevelopmentinrats |
_version_ |
1724269109696266240 |